-
Speaker Natalie Artzi Associate Professor Harvard Medical School Abstract Immunomodulatory therapies have advanced to clinical trials over the past decade for the treatment of a range of diseases and disorders, from cancer to diabetes to transplant rejection. However, the efficacy of these therapies remains limited, as challenges associated with off-target drug toxicity, poorly controlled drug […]